GILEAD SCIENCES, INC. - 10%+ Owner at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GILEAD SCIENCES, INC. since 05 Feb 2025

Holdings reported by GILEAD SCIENCES, INC. for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,635,286 $11,158,950 $0.6708 27 Jun 2023 Direct

Transactions reported by GILEAD SCIENCES, INC. for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.